We needed it to be inspiring and memorableif that wins an award and tops a ranking, awesome (wed love that too), but it was not the primary objective
Due to demand and NHS funding, the prescribing guidelines for Mounjaro on the NHS are currently stricter than those for other weight loss injections
Yes, and this is the most important interaction to understand
In functional medicine and longevity-focused care, we use it strategically in patients with: High visceral fat on imaging or InBody Central adiposity resistant to diet and exercise Low IGF-1 with metabolic dysfunction Early fatty liver patterns Why Its Different from GLP-1s GLP-1 medications reduce appetite and slow gastric emptying
Capone et al
Tirzepatide and semaglutide, both GLP-1 receptor agonists, have shown significant efficacy in weight loss and metabolic improvements, while dapagliflozin, an SGLT2 inhibitor, offers renal protection alongside metabolic benefits